Your browser doesn't support javascript.
loading
Interleukin-31 promotes pathogenic mechanisms underlying skin and lung fibrosis in scleroderma.
Yaseen, Bodoor; Lopez, Henry; Taki, Zeinab; Zafar, Sara; Rosario, Henrique; Abdi, Bahja Ahmed; Vigneswaran, Shivanee; Xing, Fiona; Arumalla, Nikita; Black, Simon; Ahmad, Sara; Kumar, Kimti; Gul, Rabia; Scolamiero, Laura; Morris, Sian; Bowman, Alex; Stainer, Anna; Rice, Alexandra; Stock, Carmel; Renzoni, Elisabetta; Denton, Christopher P; Venturini, Cristina; Brown, Max; O'Reilly, Steven; Stratton, Richard.
Afiliação
  • Yaseen B; Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital Campus, University College London Medical School, London, UK.
  • Lopez H; Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital Campus, University College London Medical School, London, UK.
  • Taki Z; MuriGenics, Inc, Vallejo, CA, USA.
  • Zafar S; Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital Campus, University College London Medical School, London, UK.
  • Rosario H; Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital Campus, University College London Medical School, London, UK.
  • Abdi BA; Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital Campus, University College London Medical School, London, UK.
  • Vigneswaran S; Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital Campus, University College London Medical School, London, UK.
  • Xing F; Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital Campus, University College London Medical School, London, UK.
  • Arumalla N; Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital Campus, University College London Medical School, London, UK.
  • Black S; Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital Campus, University College London Medical School, London, UK.
  • Ahmad S; Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital Campus, University College London Medical School, London, UK.
  • Kumar K; Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital Campus, University College London Medical School, London, UK.
  • Gul R; Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital Campus, University College London Medical School, London, UK.
  • Scolamiero L; Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital Campus, University College London Medical School, London, UK.
  • Morris S; Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital Campus, University College London Medical School, London, UK.
  • Bowman A; Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital Campus, University College London Medical School, London, UK.
  • Stainer A; Department of Respiratory Medicine, Imperial College London, Royal Brompton Campus.
  • Rice A; Department of Respiratory Medicine, Imperial College London, Royal Brompton Campus.
  • Stock C; Department of Respiratory Medicine, Imperial College London, Royal Brompton Campus.
  • Renzoni E; Department of Respiratory Medicine, Imperial College London, Royal Brompton Campus.
  • Denton CP; Department of Respiratory Medicine, Imperial College London, Royal Brompton Campus.
  • Venturini C; Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital Campus, University College London Medical School, London, UK.
  • Brown M; Pathogen Genomics Unit, UCL, London.
  • O'Reilly S; Department of Health and Life Sciences, Northumbria University, Newcastle Upon Tyne, UK.
  • Stratton R; Department of Health and Life Sciences, Northumbria University, Newcastle Upon Tyne, UK.
Rheumatology (Oxford) ; 59(9): 2625-2636, 2020 09 01.
Article em En | MEDLINE | ID: mdl-32365362
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Pele / Interleucinas / Receptores de Interleucina / Pulmão Limite: Animals / Humans Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Pele / Interleucinas / Receptores de Interleucina / Pulmão Limite: Animals / Humans Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido